drugset
Drugs / Low Molecular Weight Iron Dextran
last change Dec 2025 re-read 3 minutes ago

Low Molecular Weight Iron Dextran

Developed for
disorder of iron metabolism and transport · iron deficiency anemia
Investigated by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · University of Washington

Trials 1

today NCT05340465 · Ph 2
20232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05340465 Nov 2022 → Jan 2027 expected disorder of iron metabolism and transport, iron deficiency anemia University of Washington Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Low Molecular Weight Iron Dextran ClinicalTrials.gov intervention name — accepted as the source's own label NCT05340465 ↗
Route Intravenous “LMW-ID - 10 mg/kg/dose IV” PMID 41430711 ↗ Dec 2025